On June 20, 2014, an order regarding the application for authority to retain professionals was filed in the bankruptcy case of Savient Pharmaceuticals, Inc. and its affiliates.
The filing was assigned docket number 751 and is described on the court’s official docket as follows:
Order Terminating Employment of GCG, Inc. as Claims and Noticing Agent for the Debtors (related document(s)). Signed on 6/20/2014. (SJS)
Savient Pharmaceuticals, Inc. filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on October 14, 2013. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Delaware. The case number for the lead bankruptcy case is 13-12680. The bankruptcy case is currently assigned to United States Bankruptcy Judge Mary Walrath. The law firm of Skadden, Arps, Slate, Meagher & Flom LLP is acting as lead bankruptcy counsel to Savient Pharmaceuticals, Inc. in the bankruptcy case.